M. Karaağaç Et Al. , "The real-life outcome of pazopanib in patients with advanced soft tissue sarcoma: A retrospective cross-sectional study of a Turkish cohort," Journal of Oncology Pharmacy Practice , vol.26, no.7, pp.1657-1666, 2020
Karaağaç, M. Et Al. 2020. The real-life outcome of pazopanib in patients with advanced soft tissue sarcoma: A retrospective cross-sectional study of a Turkish cohort. Journal of Oncology Pharmacy Practice , vol.26, no.7 , 1657-1666.
Karaağaç, M., Sezgin, Y., Eryılmaz, M. K., Araz, M., Kaplan, M. A., & Artaç, M., (2020). The real-life outcome of pazopanib in patients with advanced soft tissue sarcoma: A retrospective cross-sectional study of a Turkish cohort. Journal of Oncology Pharmacy Practice , vol.26, no.7, 1657-1666.
Karaağaç, Mustafa Et Al. "The real-life outcome of pazopanib in patients with advanced soft tissue sarcoma: A retrospective cross-sectional study of a Turkish cohort," Journal of Oncology Pharmacy Practice , vol.26, no.7, 1657-1666, 2020
Karaağaç, Mustafa Et Al. "The real-life outcome of pazopanib in patients with advanced soft tissue sarcoma: A retrospective cross-sectional study of a Turkish cohort." Journal of Oncology Pharmacy Practice , vol.26, no.7, pp.1657-1666, 2020
Karaağaç, M. Et Al. (2020) . "The real-life outcome of pazopanib in patients with advanced soft tissue sarcoma: A retrospective cross-sectional study of a Turkish cohort." Journal of Oncology Pharmacy Practice , vol.26, no.7, pp.1657-1666.
@article{article, author={Mustafa Karaağaç Et Al. }, title={The real-life outcome of pazopanib in patients with advanced soft tissue sarcoma: A retrospective cross-sectional study of a Turkish cohort}, journal={Journal of Oncology Pharmacy Practice}, year=2020, pages={1657-1666} }